INTEGRIS Cancer Inst of OK

Oklahoma City, Oklahoma 73142

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Lymphocytic Leukemia, Chronic

Studies at this site

• A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) — Completed
• A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE) — Completed